Son[VEER]
NATCOPHARM
NSE: NATCOPHARM
₹810.45
Healthcare · Nifty 500 · as of 13NOV2026
Long-Term Read
• Neutral / No Clear Read · 0.43
Score
43/100
This is a percentile rank of this stock against the rest of the Nifty 500 today, not a probability or return forecast.
Long-Term Drivers
TechLong-Term Momentum
200-session price momentum.
-0.0553
as of 13NOV2026
-2 pts to score
TechSector Tailwind
Sector relative strength vs. the broader market.
0.0006
as of 13NOV2026
+1 pts to score
What changed, and when
13NOV2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Momentum (Extended)
05NOV2026
↓ Flipped to Veering Down
Driven by: Long-Term Momentum, Sector Tailwind
28OCT2026
• Flipped to Neutral / No Clear Read
Driven by: Sector Tailwind, Long-Term Momentum
06OCT2026
↓ Flipped to Veering Down
Driven by: Long-Term Momentum, Sector Momentum (Extended)
05OCT2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Momentum (Extended)
18SEP2026
↓ Flipped to Veering Down
Driven by: Long-Term Momentum, Sector Momentum (Extended)
15SEP2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Tailwind
11SEP2026
↓ Flipped to Veering Down
Driven by: Long-Term Momentum, Sector Momentum (Extended)
29JUL2026
• Flipped to Neutral / No Clear Read
Driven by: Long-Term Momentum, Sector Tailwind
28JUL2026
↑ Flipped to Veering Up
Driven by: Sector Tailwind, Long-Term Momentum
17JUL2026
• Neutral / No Clear Read · first read on record
Sector Peers · Healthcare
Past Prints
Track record begins at launch. Check back soon.